Corrigendum to “Effectiveness of L-serine supplementation in children with a GRIN2B loss-of-function mutation: Rationale and protocol for single patient (n-of-1) multiple cross-over trials” [Contemp. Clin. Trials Commun. 36 (2023)/ DOI: 10.1016/j.conctc.2023.101233] (Contemporary Clinical Trials Communications (2023) 36, (S2451865423001795), (10.1016/j.conctc.2023.101233))

Bibiche den Hollander; Marieke Rothuizen-Lindenschot; Lisa Geertjens; Frédéric M. Vaz; Marion M. Brands; Hoang Lan Le; Agnies M. van Eeghen; Peter M. van de Ven; Martina C. Cornel; Bart A.W. Jacobs; Hilgo Bruining; Clara D. van Karnebeek

doi:10.1016/j.conctc.2024.101264

Corrigendum to “Effectiveness of L-serine supplementation in children with a GRIN2B loss-of-function mutation: Rationale and protocol for single patient (n-of-1) multiple cross-over trials” [Contemp. Clin. Trials Commun. 36 (2023)/ DOI: 10.1016/j.conctc.2023.101233] (Contemporary Clinical Trials Communications (2023) 36, (S2451865423001795), (10.1016/j.conctc.2023.101233))

Bibiche den Hollander, Marieke Rothuizen-Lindenschot, Lisa Geertjens, Frédéric M. Vaz, Marion M. Brands, Hoang Lan Le, Agnies M. van Eeghen, Peter M. van de Ven, Martina C. Cornel, Bart A.W. Jacobs, Hilgo Bruining, Clara D. van Karnebeek^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Abstract

The authors regret the need for the following corrigendum: In table 1, the amino acid change for the patient is listed incorrectly. It should be p.(Arg696Leu) instead of p.(Arg820Leu). The authors would like to apologise for any inconvenience caused.

Original language	English
Article number	101264
Journal	Contemporary Clinical Trials Communications
Volume	38
DOIs	https://doi.org/10.1016/j.conctc.2024.101264
Publication status	Published - Apr 2024

Access to Document

10.1016/j.conctc.2024.101264Licence: CC BY

1-s2.0-S2451865424000115-mainFinal published version, 261 KBLicence: CC BY

Fingerprint

Dive into the research topics of 'Corrigendum to “Effectiveness of L-serine supplementation in children with a GRIN2B loss-of-function mutation: Rationale and protocol for single patient (n-of-1) multiple cross-over trials” [Contemp. Clin. Trials Commun. 36 (2023)/ DOI: 10.1016/j.conctc.2023.101233] (Contemporary Clinical Trials Communications (2023) 36, (S2451865423001795), (10.1016/j.conctc.2023.101233))'. Together they form a unique fingerprint.

1 Article

Effectiveness of L-serine supplementation in children with a GRIN2B loss-of-function mutation: Rationale and protocol for single patient (n-of-1) multiple cross-over trials
den Hollander, B., Rothuizen-Lindenschot, M., Geertjens, L., Vaz, F. M., Brands, M. M., Le, H. L., van Eeghen, A. M., van de Ven, P. M., Cornel, M. C., Jacobs, B. A. W., Bruining, H. & van Karnebeek, C. D., Dec 2023, In: Contemporary Clinical Trials Communications. 36, 101233.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access
File

Cite this

Hollander, B. D., Rothuizen-Lindenschot, M., Geertjens, L., Vaz, F. M., Brands, M. M., Le, H. L., van Eeghen, A. M., van de Ven, P. M., Cornel, M. C., Jacobs, B. A. W., Bruining, H., & van Karnebeek, C. D. (2024). Corrigendum to “Effectiveness of L-serine supplementation in children with a GRIN2B loss-of-function mutation: Rationale and protocol for single patient (n-of-1) multiple cross-over trials” [Contemp. Clin. Trials Commun. 36 (2023)/ DOI: 10.1016/j.conctc.2023.101233] (Contemporary Clinical Trials Communications (2023) 36, (S2451865423001795), (10.1016/j.conctc.2023.101233)). Contemporary Clinical Trials Communications, 38, Article 101264. https://doi.org/10.1016/j.conctc.2024.101264

Hollander, Bibiche den ; Rothuizen-Lindenschot, Marieke ; Geertjens, Lisa et al. / Corrigendum to “Effectiveness of L-serine supplementation in children with a GRIN2B loss-of-function mutation : Rationale and protocol for single patient (n-of-1) multiple cross-over trials” [Contemp. Clin. Trials Commun. 36 (2023)/ DOI: 10.1016/j.conctc.2023.101233] (Contemporary Clinical Trials Communications (2023) 36, (S2451865423001795), (10.1016/j.conctc.2023.101233)). In: Contemporary Clinical Trials Communications. 2024 ; Vol. 38.

@article{0ce620fa5a0f4461abfa5e701da03d64,

title = "Corrigendum to “Effectiveness of L-serine supplementation in children with a GRIN2B loss-of-function mutation: Rationale and protocol for single patient (n-of-1) multiple cross-over trials” [Contemp. Clin. Trials Commun. 36 (2023)/ DOI: 10.1016/j.conctc.2023.101233] (Contemporary Clinical Trials Communications (2023) 36, (S2451865423001795), (10.1016/j.conctc.2023.101233))",

abstract = "The authors regret the need for the following corrigendum: In table 1, the amino acid change for the patient is listed incorrectly. It should be p.(Arg696Leu) instead of p.(Arg820Leu). The authors would like to apologise for any inconvenience caused.",

author = "Hollander, {Bibiche den} and Marieke Rothuizen-Lindenschot and Lisa Geertjens and Vaz, {Fr{\'e}d{\'e}ric M.} and Brands, {Marion M.} and Le, {Hoang Lan} and {van Eeghen}, {Agnies M.} and {van de Ven}, {Peter M.} and Cornel, {Martina C.} and Jacobs, {Bart A.W.} and Hilgo Bruining and {van Karnebeek}, {Clara D.}",

note = "Publisher Copyright: {\textcopyright} 2024 The Author(s)",

year = "2024",

month = apr,

doi = "10.1016/j.conctc.2024.101264",

language = "English",

volume = "38",

}

Hollander, BD, Rothuizen-Lindenschot, M, Geertjens, L, Vaz, FM, Brands, MM, Le, HL, van Eeghen, AM, van de Ven, PM, Cornel, MC, Jacobs, BAW, Bruining, H & van Karnebeek, CD 2024, 'Corrigendum to “Effectiveness of L-serine supplementation in children with a GRIN2B loss-of-function mutation: Rationale and protocol for single patient (n-of-1) multiple cross-over trials” [Contemp. Clin. Trials Commun. 36 (2023)/ DOI: 10.1016/j.conctc.2023.101233] (Contemporary Clinical Trials Communications (2023) 36, (S2451865423001795), (10.1016/j.conctc.2023.101233))', Contemporary Clinical Trials Communications, vol. 38, 101264. https://doi.org/10.1016/j.conctc.2024.101264

Corrigendum to “Effectiveness of L-serine supplementation in children with a GRIN2B loss-of-function mutation: Rationale and protocol for single patient (n-of-1) multiple cross-over trials” [Contemp. Clin. Trials Commun. 36 (2023)/ DOI: 10.1016/j.conctc.2023.101233] (Contemporary Clinical Trials Communications (2023) 36, (S2451865423001795), (10.1016/j.conctc.2023.101233)). / Hollander, Bibiche den; Rothuizen-Lindenschot, Marieke; Geertjens, Lisa et al.
In: Contemporary Clinical Trials Communications, Vol. 38, 101264, 04.2024.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Corrigendum to “Effectiveness of L-serine supplementation in children with a GRIN2B loss-of-function mutation

T2 - Rationale and protocol for single patient (n-of-1) multiple cross-over trials” [Contemp. Clin. Trials Commun. 36 (2023)/ DOI: 10.1016/j.conctc.2023.101233] (Contemporary Clinical Trials Communications (2023) 36, (S2451865423001795), (10.1016/j.conctc.2023.101233))

AU - Hollander, Bibiche den

AU - Rothuizen-Lindenschot, Marieke

AU - Geertjens, Lisa

AU - Vaz, Frédéric M.

AU - Brands, Marion M.

AU - Le, Hoang Lan

AU - van Eeghen, Agnies M.

AU - van de Ven, Peter M.

AU - Cornel, Martina C.

AU - Jacobs, Bart A.W.

AU - Bruining, Hilgo

AU - van Karnebeek, Clara D.

PY - 2024/4

Y1 - 2024/4

N2 - The authors regret the need for the following corrigendum: In table 1, the amino acid change for the patient is listed incorrectly. It should be p.(Arg696Leu) instead of p.(Arg820Leu). The authors would like to apologise for any inconvenience caused.

AB - The authors regret the need for the following corrigendum: In table 1, the amino acid change for the patient is listed incorrectly. It should be p.(Arg696Leu) instead of p.(Arg820Leu). The authors would like to apologise for any inconvenience caused.

UR - http://www.scopus.com/inward/record.url?scp=85184756377&partnerID=8YFLogxK

U2 - 10.1016/j.conctc.2024.101264

DO - 10.1016/j.conctc.2024.101264

M3 - Comment/Letter to the editor

AN - SCOPUS:85184756377

SN - 2451-8654

VL - 38

JO - Contemporary Clinical Trials Communications

JF - Contemporary Clinical Trials Communications

M1 - 101264

ER -

Hollander BD, Rothuizen-Lindenschot M, Geertjens L, Vaz FM, Brands MM, Le HL et al. Corrigendum to “Effectiveness of L-serine supplementation in children with a GRIN2B loss-of-function mutation: Rationale and protocol for single patient (n-of-1) multiple cross-over trials” [Contemp. Clin. Trials Commun. 36 (2023)/ DOI: 10.1016/j.conctc.2023.101233] (Contemporary Clinical Trials Communications (2023) 36, (S2451865423001795), (10.1016/j.conctc.2023.101233)). Contemporary Clinical Trials Communications. 2024 Apr;38:101264. doi: 10.1016/j.conctc.2024.101264

Abstract

Access to Document

Other files and links

Fingerprint

Research output

Effectiveness of L-serine supplementation in children with a GRIN2B loss-of-function mutation: Rationale and protocol for single patient (n-of-1) multiple cross-over trials

Cite this